PaMeLa Inc. is pleased to announce that we have been selected for the “J-StarX Medtech Course,” a global expansion support program for medical and healthcare startups jointly organized by the
Japan External Trade Organization (JETRO) and MedTech Actuator.

This program is a hands-on accelerator designed to help Japan-based companies enter global markets by building business strategies, forming networks with overseas healthcare institutions, and deepening their understanding of regulatory and reimbursement pathways.

From PaMeLa, CEO Hiroaki Goto and Executive Officer Yamamoto are scheduled to visit Melbourne, Australia, in October 2025. Through engagements with medical institutions and industry stakeholders, they will share our business initiatives and future outlook while creating partnerships to support market entry in Australia.

Leveraging this selection, PaMeLa will further accelerate its global expansion and advance the real-world implementation of its technology for the objective assessment of pain.